News | April 29, 2023
Evonik starts construction of new U.S. facility for pharmaceutical lipids
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Subscribe To Our Newsletter & Stay Updated
